NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment
ConditionNeurodevelopmental Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age24-34
SponsorSt. Justine's Hospital
About this trial
NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.
Eligibility criteria
Qualifiers
born between 24 and 33 6/7 weeks GA;
ready for SSC
agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant;
mothers express breast milk for their preterm infants
Disqualifiers
congenital anomalies or genetic disorders
intraventricular hemorrhage > grade II
are small for GA defined as birth weight <10th percentile
on postnatal day 19 (maximum days targeted for study start)
Trial design
Treatments tested in this trial
- NeuroN-QI
- SSC alone
Treatment groups
124 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov